Saratoga Research & Investment Management Portfolio Shifts in Q2 2026
Saratoga's portfolio saw significant changes this quarter with notable purchases of Intuitive Surgical, Emerson Electric, Baycom Corp and sales from Alphabet Inc., Novo Nordisk A/S, Microsoft Corp.
SARATOGA RESEARCH & INVESTMENT MANAGEMENT has released its latest portfolio activity report for the period ending June 30th, 2026. The firm's substantial investment strategy continues to evolve as they navigate market conditions and focus on specific growth opportunities.
Among the most significant actions this quarter were new positions initiated in Intuitive Surgical Inc, commonly known by its ticker symbol ISRG. Saratoga purchased 38,044 shares of this highly specialized medical technology company, effectively doubling their stake and signaling strong confidence in the sector's prospects.
Similarly, Emerson Electric Co, identified by its ticker EMR, saw a 100% increase in Saratoga's holdings. The firm added 71,924 shares during this quarter, representing a significant new investment allocation.
Baycom Corp (BCML) also attracted attention with Saratoga establishing a brand-new position entirely through purchases. This move suggests the investor services firm sees potential in this financial services entity despite its small current allocation of just 0.06%.
In contrast, Saratoga significantly reduced exposure to several large-cap technology and healthcare companies. Alphabet Inc (GOOGL) experienced an 18.38% reduction in holdings as the firm sold over 112,000 shares during this period.
Novo Nordisk A/S (NVO), a major player in the healthcare sector, also saw substantial selling pressure from Saratoga Research & Investment Management (-5.83%). Similarly, Microsoft Corp (MSFT) faced significant divestment with an approximate 9.4% reduction in shares.
Interestingly, despite adding to positions like EMR and ISRG, the firm also sold a large stake of NVIDIA Corp (NVDA). However, this sale was preceded by a massive increase during the quarter - Saratoga purchased approximately 48,000 additional shares. This suggests either a strategic rebalancing or that the previous period's holdings were exceptionally low.
The overall portfolio turnover rate remains high for an investment manager like Saratoga Research & Investment Management, with significant changes observed across multiple sectors and stocks during this reporting quarter.